Evaluation of the impact of the recent controversy over statins in France: The EVANS study

Amarenco, 2004, Statins in stroke prevention and carotid atherosclerosis: systematic review and up-to-date meta-analysis, Stroke, 35, 2902, 10.1161/01.STR.0000147965.52712.fa Armitage, 2010, Intensive lowering of LDL cholesterol with 80mg versus 20mg simvastatin daily in 12,064 survivors of myocardial infarction: a double-blind randomised trial, Lancet, 376, 1658, 10.1016/S0140-6736(10)60310-8 Briel, 2006, Effects of early treatment with statins on short-term clinical outcomes in acute coronary syndromes: a meta-analysis of randomized controlled trials, JAMA, 295, 2046, 10.1001/jama.295.17.2046 Kearney, 2008, Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis, Lancet, 371, 117, 10.1016/S0140-6736(08)60104-X Kizer, 2010, Relation of different measures of low-density lipoprotein cholesterol to risk of coronary artery disease and death in a meta-regression analysis of large-scale trials of statin therapy, Am J Cardiol, 105, 1289, 10.1016/j.amjcard.2009.12.051 Ridker, 2008, Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein, N Engl J Med, 359, 2195, 10.1056/NEJMoa0807646 Brugts, 2009, The benefits of statins in people without established cardiovascular disease but with cardiovascular risk factors: meta-analysis of randomised controlled trials, BMJ, 338, b2376, 10.1136/bmj.b2376 Mihaylova, 2012, The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials, Lancet, 380, 581, 10.1016/S0140-6736(12)60367-5 Ray, 2010, Statins and all-cause mortality in high-risk primary prevention: a meta-analysis of 11 randomized controlled trials involving 65,229 participants, Arch Intern Med, 170, 1024, 10.1001/archinternmed.2010.182 Kelly, 2009, The HPV vaccine and the media: how has the topic been covered and what are the effects on knowledge about the virus and cervical cancer?, Patient Educ Couns, 77, 308, 10.1016/j.pec.2009.03.018 Tuppin, 2013, Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010, Arch Cardiovasc Dis, 106, 274, 10.1016/j.acvd.2013.02.005 Gollust, 2013, Political and news media factors shaping public awareness of the HPV vaccine, Womens Health Issues, 23, e143, 10.1016/j.whi.2013.02.001 Rutten, 2009, Health information seeking and media exposure among smokers: a comparison of light and intermittent tobacco users with heavy users, Nicotine Tob Res, 11, 190, 10.1093/ntr/ntn019 Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian simvastatin survival study (4S). Lancet 1994; 344:1383-9. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The long-term intervention with pravastatin in ischaemic disease (LIPID) study group. N Engl J Med 1998; 339:1349-57. Law, 2003, Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis, BMJ, 326, 1423, 10.1136/bmj.326.7404.1423 Shepherd, 1995, Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland coronary prevention study group, N Engl J Med, 333, 1301, 10.1056/NEJM199511163332001 Chapman, 2011, Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management, Eur Heart J, 32, 1345, 10.1093/eurheartj/ehr112 Perk, 2012, Eur Heart J, 33, 1635, 10.1093/eurheartj/ehs092 Taylor, 2013, Statins for the primary prevention of cardiovascular disease, Cochrane Database Syst Rev, 1, CD004816 Mitchell, 2012, Statin cost effectiveness in primary prevention: a systematic review of the recent cost-effectiveness literature in the United States, BMC Res Notes, 5, 373, 10.1186/1756-0500-5-373 Morrison, 2003, Determinants of the cost-effectiveness of statins, J Manag Care Pharm, 9, 544, 10.18553/jmcp.2003.9.6.544 Pletcher, 2009, Comparing impact and cost-effectiveness of primary prevention strategies for lipid-lowering, Ann Intern Med, 150, 243, 10.7326/0003-4819-150-4-200902170-00005 Tuppin, 2010, Evidence-based pharmacotherapy after myocardial infarction in France: adherence-associated factors and relationship with 30-month mortality and rehospitalization, Arch Cardiovasc Dis, 103, 363, 10.1016/j.acvd.2010.05.003